Therapeutic Area Lead, Lymphoid & Myeloid Malignancies, Medical Affairs Oncology

Key Responsibilities

• The TAL, LMM will be part of the Medical Affairs Leadership Team.
• Lead a group of Medical Directors (MDs) to develop overall strategy for lymphoid and myeloid malignancy products and pipeline and emerging assets.
• Provides strategic Medical Affairs leadership for pipeline and emerging products, partnering cross-functionally to assess evolving scientific and medical needs and establish strategies that support portfolio evolution and future asset readiness.
• Identify and devise strategies to address crucial gaps using critical relationships across Medical Affairs, Global Medical Affairs, R&D, RW V&E (HECOR), Commercial, and others.
• Lead and effectively partner with relevant Alliance partner companies on those activities.
• Elevates needs for funding to MA VP and US Franchise President.
• Provide medical monitoring and medical oversight for company-sponsored Medical Affairs-led interventional and observational clinical trials.
• Oversee development and implementation of Investigator Initiated Study (IIS) strategy and assess and supervise IIS conduct with the support of direct reports.
• Oversee the medical support in the development of compliant promotional materials and the training of product representatives; will adequately support Commercial functions.
• Oversee development and implementation of Advisory Board strategy and maintain relationships with external investigators and opinion leaders.
• Ensures development of scholarly publications arising from Johnson & Johnson Medical Affairs studies and works with Scientific Communications team on broader communication strategy.
• Supports the development of product monographs and responses to product inquiries.

MSL Head / Field Medical Leadership Responsibilities

• Serves concurrently as the MSL Head for Lymphoid and Myeloid Malignancies, including pipeline and emerging products, with accountability for establishing the overall Field Medical strategy and ensuring alignment with the broader therapeutic area and Medical Affairs strategy.
• Leads two Field Directors responsible for the execution of the Field Medical strategy across the Lymphoid and Myeloid Malignancies MSL organization.
• Sets strategic direction and priorities for the Field Medical organization, translating therapeutic area objectives, evidence needs, pipeline priorities, and evolving scientific needs into a clear and actionable field strategy.
• Leads the Field Medical strategy across current and emerging Lymphoid and Myeloid Malignancy products, ensuring the organization is positioned to support evolving portfolio priorities and future asset readiness.
• Partners closely with the Field Directors to ensure consistent execution of the field strategy, appropriate prioritization of MSL activities, and alignment of field resources against the highest-priority scientific and medical needs.
• Provides leadership and direction on MSL engagement priorities, including scientific exchange, external stakeholder engagement, insight generation, and identification of emerging medical and scientific needs across the therapeutic area.
• Ensures high-quality insights from the field are synthesized and incorporated into therapeutic area strategy, evidence generation priorities, scientific communications, and pipeline planning.
• Creates connectivity between headquarters and Field Medical teams, ensuring strategic priorities are effectively translated into field execution and field perspectives are represented in Medical Affairs decision-making.
• Provides leadership, coaching, and development to the Field Directors, fostering strong leadership capability and a high-performing Field Medical organization.
• Partners across Medical Affairs and other relevant functions to ensure the Field Medical strategy evolves with the scientific landscape, portfolio priorities, and needs of healthcare professionals and patients.
• Establishes appropriate measures of Field Medical effectiveness and uses field insights and performance indicators to inform ongoing refinement of strategy and execution.

Qualifications

• MD (Medical Oncologist and/or Hematologist) is preferred.
• Experience and knowledge in treatment of lymphoid and myeloid malignancies, drug development and Medical Affairs is required.
• A strong insight into the lymphoid and myeloid malignancy therapeutic area and knowledge of the US market is required.
• 10 years or more (including subspecialty training) with 5 or more years' experience in the pharmaceutical industry is required.
• Strong track record in developing and implementing clinical research and medical strategies including evaluation of value-oriented research and communication strategies.
• People management experience is required.
• Ability to travel up to 30% both domestically and/or internationally is required.